Introduction: To assess the impact of delayed vs immediate pre-operative lymphoscintigraphy (LSG) for sentinel lymph node biopsy in a single Australian tertiary breast cancer centre. Methods: Retrospective cohort study analysing patients with breast cancer or DCIS who underwent lumpectomy or mastectomy with pre-operative LSG and intra-operative sentinel lymph node biopsy from January 2015 to June 2016. Results: A total of 182 LSG were performed. Group A patients had day before pre-operative LSG mapping (n = 79) and Group B had LSG mapping on the day of surgery (n = 103). The overall LSG localisation rate was 97.3% and no statistical difference was detected between the two groups. The overall sentinel lymph node biopsies (SLN) were identified in 99.6% of patients. The number of nodes excised was slightly higher in Group A (1.90 vs 1.72); however, this was not statistically significant. In addition, the number of nodes on histopathology and the incidence of second echelon nodal detection were also similar between the two groups without statistical significance. Conclusion: In conclusion, the 2-day LSG protocol had no impact on overall SLNB and LSG detection rates although slightly higher second tier nodes but this did not translate to any difference between the number of harvest nodes between the two groups. The 2-day LSG allows for greater flexibility in theatre planning and more efficient use of theatre time. We recommend a dose of 40 Mbq of Tc99 m pertechnetate-labelled colloid be given day prior to surgery within a 24-hour timeframe.
Introduction
Sentinel lymph node biopsy (SLNB) is routinely performed in all clinically negative axilla patients undergoing surgery for early breast cancer. The SLN status is important in determining the choice of adjuvant therapy and provides prognostic information. 1 Pre-operative lymphoscintigraphy (LSG) helps to identify axillary sentinel lymph nodes, non-axillary nodes and the presence of multiple lymph nodes in surgical planning for early breast cancer. Failure to identify a hot node on LSG can alert surgeons to increased risk of failure. Pre-operative radiocolloid injection is performed in the nuclear medicine department before the patient is presented to theatre.
On the theatre day, patient is often rushed between radiology, nuclear medicine before going to operating theatre. It is often not possible if the patient is first on the list. Having injection on the same day can create problems with coordinating patient flow. Some centres and studies have shown a 2-day protocol, i.e. having injection day before to be safe and accurate for LSG. [2] [3] [4] [5] [6] However, the main concern is the possibility of washout of radioisotopes to second echelon nodes or non-sentinel lymph nodes if time between injection and surgery is left too long. 7 Injecting isotopes day before the procedure can help to reduce time pressure on operating room scheduling. The aim of this study was to determine whether having injection of radioactive tracer day before the surgery has any impact on the intra-operative sentinel lymph node detection, overall LSG localisation rate, the number of second echelon nodes on LSG imaging and any effect on the number of harvested sentinel lymph nodes.
Methods
We performed a retrospective study from 183 consecutive clinically axillary node negative patients with early breast cancer from January 2015 to May 2016 who underwent SLNB with pre-operative LSG at a tertiary breast centre by four specialised breast surgeons.
Patients who received neoadjuvant therapy were excluded. Patients were not randomly assigned, but were allocated to have injection day before with higher dose of radiocolloid on the basis of their preference and the scheduling of the procedure. The isotope used in our centre was Tc99 m antimony trisulfide colloid with a filtered size around 20 nm. A LSG image is performed between 10 and 60 minutes post-injection. If there is no signal from the first injection, a second injection is performed and repeat LSG image is again performed. Injections were given by Nuclear physicians, Nuclear Medicine registrars or qualified Nuclear Medicine technologists; most injections were injected in an intradermal, periareolar and tumour quadrant fashion. The 1-day protocol consisted 10 mBq (mean 10.4 AE 1.9) injected on the morning of scheduled surgery, while the 2-day protocol consisted 40 mBq (mean 42.4 AE 6.2) day before (<24 hours). In the 2-day protocol group, no follow-up images were obtained on the morning of surgery. Not all patients routinely will have blue dye injection. We also measured the number of second tier nodes on LSG images from two clinicians. The number of additional non-sentinel lymph nodes was counted from histopathology reports. The following parameters were recorded: patient's age, BMI, previous breast surgery, timing of LSG imaging, cancer histology type, tumour size, number of sentinel lymph nodes harvested, number of nonsentinel lymph nodes harvested, use of blue dye, the presence of intradermal injection, injection location, dose injected, the presence of second injection, who performed the injection (medical vs technician), time between injection and start of surgery, and the presence of positive sentinel lymph node.
Results
Baseline patient demographics were similar between the two groups as shown in Tables 1 and 2 . Primary tumour size was slightly larger in the 2-day group (26.1 mm vs 19.6 mm). Invasive ductal carcinoma was the most common pathology in both groups, followed by invasive lobular carcinoma and ductal carcinoma in situ (DCIS). No statistical difference was detected between positive sentinel lymph node rates between the two groups.
Injection factors were comparative between the two groups. Both groups had similar percentage of technician performing the injection. However, there were few tumour quadrant injections performed in the 2-day group 88.6% vs 1-day group 97.1%. More patients received 'lateral, i.e. 3 or 9 O'clock' position injections in the 2-day group. The mean injection to surgery time was 259 AE 98 minutes in the 1-day group and 1162 AE 167 minutes in the 2-day group.
Overall, our centre's sentinel lymph node intra-operative detection rate was excellent, 99% in the 1-day group and 100% in the 2-day group. LSG were able to identify 96% in the 1-day group and 97% in the 2-day group as shown on Table 3 .
There was no difference in the number of non-sentinel lymph nodes excised between the two groups (1-day 0.17 AE 0.8 vs 2-day 0.14 AE 0.46). However, there was a slight increase in the number of second tier nodes shown on LSG images in the 2-day group (1.87 AE 1.8 vs 1.25 AE 1.4, p = 0.01), as shown on Table 4 , this is possibly from SLNB pre-operative LSG day before impact more background scattering. The slight increase in the number of second tier nodes did not translate into significant increase in the average number of sentinel lymph nodes excised. In the 1-day group, an average of 1.72 AE 1.3 nodes were excised compared to the 2-day group with an average of 1.90 AE 0.9 nodes excised (P = 0.28) as shown on Table 5 .
Discussion
Sentinel lymph node biopsy is still commonly used in staging the axilla in clinically negative patients with early breast cancer. Pre-operative LSG helps to identify axillary sentinel lymph nodes, non-axillary nodes and presence of multiple lymph nodes in surgical planning for early breast cancer. Failure to identify a hot node on LSG can alert surgeons to increased risk of failure. In our specialised tertiary institute's, overall intraoperative sentinel lymph node detection rate was excellent, despite low usage rate of blue dye; this could be explained by more familiarity with the procedure and experienced breast surgeons in the unit. Our results are comparable to the Australian National date. 8 See Table 3 .
The two groups had very similar demographics and also overall outcomes. There was no difference observed in the number of average sentinel nodes harvested (1.90 vs 1.72, P = 0.28). This finding has also been replicated in similar studies from the USA Europe. 2, 3, 5, 9, 10 Multiple studies have confirmed the optimal number of sentinel lymph node for SLNB is between 2 and 3. [11] [12] [13] We do know the higher the number of nodes harvested can lead to lower false negative rates, but this does predispose patient to more surgical related complications. We do not routinely perform axillary dissection and as a result this false negative rate of SLNB cannot be calculated. In terms of overall LSG sentinel lymph node detection rate, in the 2-day group, LSG only failed to identify one patient out of a total of 79 patients. This patient received blue dye injection intra-operatively and had successful intra-operative blue dye detection. Final histopathology for this patient demonstrated 18 out of 18 positive metastatic lymph nodes. This may explain why LSG had failed to detect a SLN, as axillary metastasis may be related to obstruction of the lymphatic channels from metastatic disease. While, in the 1-day group, LSG failed to detect SLN in 3 out of 103 patients. One of the three patients did not have SLN detected on blue dye as well. This patient did not have axillary clearance at the time, as her primary tumour was deemed low risk with size <10 mm, grade 1, ER and PR positive. The other two patients, initial LSG images did not detect any SLN and a second injection was not able to be performed due to time constraints and theatre pressure, as both patients were requested to go to the operating theatre, intra-operatively blue dye was used in one patient and intra-operative SLNs signals were positive in both patients. This demonstrates the important role of LSG imaging vs using the gamma probe alone intra-operatively. A failed LSG can prompt the surgical team to consider using patent blue dye and to have lower index of suspicion for a failed intra-operative SLNB and therefore considering the application of surgical exploration +/À axillary dissection. An additional value of LSG imaging is the demonstration on unexpected sites of sentinel lymph nodes such as the internal mammary or contralateral axillary stations.
Concern regarding day-before protocol is from the migration of radiotracer to non-sentinel nodes. The speed of migration and retention time in the sentinel lymph node of a radiotracer is related to the size of the radiolabelled particles. Smaller the radiolabelled particle more likely second echelon nodes are identified. In our institution, our radiocolloid has an average size of 20 nm. Studies from earlier years from Babiera et al. with 15 participants also found drainage patterns between early (15 minutes-4 hours) and delayed LSG (18-24 hours). Multiple other studies have also confirmed the efficacy of having injection day before surgery date. [14] [15] [16] The role of SPECT/CT imaging in LSG is limited as planar imaging is usually sufficient. SPECT/CT may help to improve the sensitivity of SLN detection, allow for more precise anatomical localisation and surgical approach for SLNB, especially in patients with unusual lymphatic drainage. 17 SPECT/CT may also be a useful conjunct in obese patients (BMI >30). 17 However, this technique is limited by requirement for extra time and larger radiation dose without demonstrating reduction in overall breast cancer axilla recurrence rate. 17 Therefore, this technique should only be performed in selected patients.
Limitations from the study are retrospective design and relatively small number of patients. This is explained by the relatively newly opened hospital and the change in the radioisotope from June 2016, switching from Lymphflo to Austin Health Supplier due to Logistic issues.
In conclusion, the 2-day LSG protocol had no impact on overall SLNB and LSG detection rates although slightly higher second tier nodes but this did not 
